Skip to main content
Article thumbnail
Location of Repository

Methods Design: Randomized placebo-controlled trial (Aliskiren Trial in



Aliskiren increased adverse events in patients with diabetes and kidney disease who were receiving ACE inhibitors or ARB

Year: 2013
OAI identifier: oai:CiteSeerX.psu:
Provided by: CiteSeerX
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.